The British Medicines and Healthcare products Regulatory Agency (MHRA) are considering to stop the rollout of the Oxford vaccine in the under 30s over fears of people dying from a rare blood clot.
Channel 4 News reported that the MHRA are considering to restrict the Oxfrod AstraZeneca vaccine in tounger people, and the decision could be made today.
Dr June Raine Chief executive of the MHRA said, “People should continue to get their vaccine when inveited to do so.
“Our thorough and detailed review is ongoing into reports of very rare and specific types of blood clots with low platelets following the Covid-19 Vaccine AstraZeneca.
“No decision has yet been made on any regulatory action.”
However, Professor Neil Ferguson of Imperial College London said the MHRA and the Joint Committee on Vaccination and Immunisation (JCVI) are urgently “considering this matter.”
He added, “No vaccine, no medicine is risk free, it is always about a balancing equation against risk.”
Professor Ferguson told Today, “In terms of the data at the moment, there is increasing evidence that there is a rare risk associated, particularly with the AstraZeneca vaccine, but it may be associated at a lower level with other vaccines, of these unusual blood clots with low platelet counts.
“It appears that risk is age related, it may be possible, but the data is weaker on this related to sex.
“And so the older you are, the less the risk is and also the higher the risk is of Covid so the risk-benefit equation really points very much towards being vaccinated.
“I think it becomes slightly more complicated when you get to younger age groups where the risk-benefit equation is more complicated.”